N. Castro

发表

Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3

J. Martínez-López, R. Ayala, D. Rueda, 2012, British journal of haematology.

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

J. Briones, A. López-Guillermo, M. Terol, 2018, British journal of haematology.

Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study

Marcos González, A. Oriol, M. Sanz, 2015, Haematologica.

MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia

G. Gómez-López, I. Rapado, J. Martínez-López, 2019, Scientific Reports.

Endothelial-specific deficiency of megalin in the brain protects mice against high-fat diet challenge

A. Camins, E. Carro, D. Antequera, 2020, Journal of Neuroinflammation.

CALR mutations screening should not be studied in splanchnic vein thrombosis

I. Rapado, J. Martínez-López, R. Ayala, 2015, British journal of haematology.

Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology

M. González-Díaz, I. Buño, E. Barragán, 2018, British journal of haematology.

Alzheimer's disease-like impaired cognition in endothelial-specific megalin-null mice.

M. Dietrich, E. Carro, D. Antequera, 2014, Journal of Alzheimer's disease : JAD.

Endothelial-specific deficiency of megalin in the brain protects mice against high-fat diet challenge

A. Camins, E. Carro, D. Antequera, 2020, Journal of Neuroinflammation.

Quantification of Antiphospholipid Antibodies: The Importance of Using an Appropriate Methodology for Each Clinical Profile

O. Cabrera-Marante, M. Serrano, E. Paz-Artal, 2023, International journal of molecular sciences.